134 related articles for article (PubMed ID: 3032954)
1. Identification of a factor IX/IXa binding protein on the endothelial cell surface.
Rimon S; Melamed R; Savion N; Scott T; Nawroth PP; Stern DM
J Biol Chem; 1987 May; 262(13):6023-31. PubMed ID: 3032954
[TBL] [Abstract][Full Text] [Related]
2. The binding of factor IXa to cultured bovine aortic endothelial cells. Induction of a specific site in the presence of factors VIII and X.
Stern DM; Nawroth PP; Kisiel W; Vehar G; Esmon CT
J Biol Chem; 1985 Jun; 260(11):6717-22. PubMed ID: 3922979
[TBL] [Abstract][Full Text] [Related]
3. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
[TBL] [Abstract][Full Text] [Related]
4. Comparative interactions of factor IX and factor IXa with human platelets.
Ahmad SS; Rawala-Sheikh R; Walsh PN
J Biol Chem; 1989 Feb; 264(6):3244-51. PubMed ID: 2492533
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody to factor IX that inhibits the factor VIII:Ca potentiation of factor X activation.
Bajaj SP; Rapaport SI; Maki SL
J Biol Chem; 1985 Sep; 260(21):11574-80. PubMed ID: 3930478
[TBL] [Abstract][Full Text] [Related]
6. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.
Ahmad SS; Walsh PN
Biochemistry; 2002 Sep; 41(37):11269-76. PubMed ID: 12220193
[TBL] [Abstract][Full Text] [Related]
7. Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme.
Lenting PJ; ter Maat H; Clijsters PP; Donath MJ; van Mourik JA; Mertens K
J Biol Chem; 1995 Jun; 270(25):14884-90. PubMed ID: 7797466
[TBL] [Abstract][Full Text] [Related]
8. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding.
Lenting PJ; Christophe OD; Maat H; Rees DJ; Mertens K
J Biol Chem; 1996 Oct; 271(41):25332-7. PubMed ID: 8810297
[TBL] [Abstract][Full Text] [Related]
9. Binding of coagulation factors IX and X to the endothelial cell surface.
Heimark RL; Schwartz SM
Biochem Biophys Res Commun; 1983 Mar; 111(2):723-31. PubMed ID: 6404275
[TBL] [Abstract][Full Text] [Related]
10. The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX.
Lenting PJ; van de Loo JW; Donath MJ; van Mourik JA; Mertens K
J Biol Chem; 1996 Jan; 271(4):1935-40. PubMed ID: 8567641
[TBL] [Abstract][Full Text] [Related]
11. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
[TBL] [Abstract][Full Text] [Related]
12. Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.
Castillo MJ; Kurachi K; Nishino N; Ohkubo I; Powers JC
Biochemistry; 1983 Mar; 22(5):1021-9. PubMed ID: 6601494
[TBL] [Abstract][Full Text] [Related]
13. Binding of factors IX and IXa to cultured vascular endothelial cells.
Stern DM; Drillings M; Nossel HL; Hurlet-Jensen A; LaGamma KS; Owen J
Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4119-23. PubMed ID: 6602986
[TBL] [Abstract][Full Text] [Related]
14. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors.
Fuchs HE; Trapp HG; Griffith MJ; Roberts HR; Pizzo SV
J Clin Invest; 1984 Jun; 73(6):1696-703. PubMed ID: 6202716
[TBL] [Abstract][Full Text] [Related]
15. A pathway of coagulation on endothelial cells.
Nawroth PP; Stern DM
J Cell Biochem; 1985; 28(4):253-64. PubMed ID: 3877062
[TBL] [Abstract][Full Text] [Related]
16. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
[TBL] [Abstract][Full Text] [Related]
17. Kinetic comparison of bovine blood coagulation factors IXa alpha and IXa beta toward bovine factor X.
Link RP; Castellino FJ
Biochemistry; 1983 Aug; 22(17):4033-41. PubMed ID: 6412750
[TBL] [Abstract][Full Text] [Related]
18. Baculovirus-mediated expression of the epidermal growth factor-like modules of human factor IX fused to the factor XIIIa transamidation site in fibronectin. Evidence for a direct interaction between the NH2-terminal epidermal growth factor-like module of factor IXa beta and factor X.
Astermark J; Sottile J; Mosher DF; Stenflo J
J Biol Chem; 1994 Feb; 269(5):3690-7. PubMed ID: 7906269
[TBL] [Abstract][Full Text] [Related]
19. Structural determinants of the factor IX molecule mediating interaction with the endothelial cell binding site are distinct from those involved in phospholipid binding.
Ryan J; Wolitzky B; Heimer E; Lambrose T; Felix A; Tam JP; Huang LH; Nawroth P; Wilner G; Kisiel W
J Biol Chem; 1989 Dec; 264(34):20283-7. PubMed ID: 2555350
[TBL] [Abstract][Full Text] [Related]
20. Factor IX Amagasaki: a new mutation in the catalytic domain resulting in the loss of both coagulant and esterase activities.
Miyata T; Sakai T; Sugimoto M; Naka H; Yamamoto K; Yoshioka A; Fukui H; Mitsui K; Kamiya K; Umeyama H
Biochemistry; 1991 Nov; 30(47):11286-91. PubMed ID: 1958666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
